United Therapeutics (UTHR) FCF Margin (2009 - 2026)
United Therapeutics (UTHR) posted FCF Margin of 46.54% for Q1 2026, down 36.32% sequentially from 73.08% in Q4 2025, and down 209.0% YoY from 42.7% in Q1 2025.
United Therapeutics (UTHR) FCF Margin (2009 - 2026) Analysis & Trends
United Therapeutics has reported FCF Margin for 18 years, with the latest figure at 46.54% in Q1 2026.
- Quarterly FCF Margin fell 209.0% year-over-year to 46.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 44.87% (up 766.0% YoY) and the FY2025 annual result came in at 45.4%, up 784.0% from the prior year.
- FCF Margin retreated to 46.54% in Q1 2026 per UTHR's latest filing, from 73.08% in the prior quarter.
- Over five years, FCF Margin peaked at 73.08% in Q4 2025 and troughed at 6.49% in Q2 2023.
- A 5-year average of 41.82% and a median of 40.15% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin tumbled 2506 bps in 2024, then surged 3850 bps in 2025.
- Over 5 years, FCF Margin stood at 25.94% in 2022, then grew by 5 bps to 27.18% in 2023, then increased by 27 bps to 34.58% in 2024, then jumped by 111 bps to 73.08% in 2025, then plunged by 36 bps to 46.54% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 46.54%, 73.08%, and 35.11% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 27.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.25% |
| Mar 31, 2026 | 46.54% |
| Dec 31, 2025 | 73.08% |
| Sep 30, 2025 | 35.11% |
| Jun 30, 2025 | 25.09% |
| Mar 31, 2025 | 48.63% |
| Dec 31, 2024 | 34.58% |
| Sep 30, 2024 | 40.15% |
| Jun 30, 2024 | 24.13% |
| Mar 31, 2024 | 52.07% |
| Dec 31, 2023 | 27.18% |
| Sep 30, 2023 | 65.21% |
| Jun 30, 2023 | 6.49% |
| Mar 31, 2023 | 70.31% |
| Dec 31, 2022 | 25.94% |
| Sep 30, 2022 | 53.35% |
| Jun 30, 2022 | 23.56% |
| Mar 31, 2022 | 59.58% |
| Dec 31, 2021 | 25.05% |
| Sep 30, 2021 | 31.19% |